Ductal carcinoma in situ of breast: update 2019
- PMID: 31472981
- PMCID: PMC6788802
- DOI: 10.1016/j.pathol.2019.07.005
Ductal carcinoma in situ of breast: update 2019
Abstract
Ductal carcinoma in situ is a non-invasive form of breast cancer. Its incidence is increasing due to widespread use of mammographic screening. It presents several diagnostic and management challenges in part due to its relatively indolent behaviour. Most series analysing biomarkers in these lesions are small (<100 patients) and large clinical trials have not been frequent. Herein, we review the recent progress made in understanding the biology of this entity and the tools available for prognostication.
Keywords: Breast cancer; DCIS; ductal carcinoma in situ; molecular features; pathology.
Copyright © 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.
Figures
References
-
- DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 2017; 67: 439–48. - PubMed
-
- DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin 2011; 61: 409–18. - PubMed
-
- Allegra CJ, Aberle DR, Ganschow P, et al. National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22–24, 2009. J Natl Cancer Inst 2010; 102: 161–9. - PubMed
-
- Lester SC, Connolly JL, Amin MB. College of American Pathologists protocol for the reporting of ductal carcinoma in situ. Arch Pathol Lab Med 2009; 133: 13–4. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
